This federal contract award is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,147.92 firm fixed-price delivery order is placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 21, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs.
Generated 2/19/25, 9:19 AM